dave Rosa has said Nasdaq listing by mid february and european approval by mid year.
Sounds like we will get the money, just on tougher terms.
SHC is on its way.
http://www.fiercebiotech.com/story/biotech-execs-leave-jp-morgan-mixed-feelings-about-year-ahead-page-2/2012-01-12
Add to My Watchlist
What is My Watchlist?